Delivery Order SPE2DB22D9367-SPE2DB24FSY58

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,573.50, is for the delivery of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $15,032.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the procurement of BEYFORTUS 100 MG/ML SYRINGEML, with a completion date of September 30, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $50,490.00 firm fixed-price contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a period of performance through August 28, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $18,107.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through February 2, 2024, is for the supply of the pharmaceutical product BEYFORTUS 100 MG/ML SYRINGEML. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a significant indefinite delivery contract (IDC) with the DLA under the...
The Defense Logistics Agency awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The order, valued at $21,729.24, has a completion date of February 2, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 and supports...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,917.34 firm fixed-price delivery order is for BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product, under the DLA's Medical Supply Chain program. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $9,053.85 order is for BEYFORTUS 100 MG/ML SYRINGEML and is part of a larger, single-award indefinite delivery contract valued up to $4,999,999 through 2025. The contract enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $14,486.24 order is for BEYFORTUS 100 MG/ML SYRINGEML with a completion date of February 2, 2024. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract with DLA valued up to $4,999,999 through 2025 to provide a broad range of pharmaceutical items to military health facilities....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,917.34, is for the supply of the pharmaceutical product BEYFORTUS 100 MG/ML SYRINGEML. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, which has a ceiling value of up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,711.25 delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order and is not associated with a set-aside designation. DMS Pharmaceutical...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY58
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,978.75 contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML and has a completion date of July 9, 2024.

DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This specific award complements the company's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites. DMS Pharmaceutical Group specializes in providing a variety of branded and generic pharmaceuticals, biologics, and medical consumables to government agencies, primarily the DoD and Department of Veterans Affairs.

Generated 10/7/24, 10:56 AM